Ali Tavakoli

Dr. Ali Tavakoli


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
ATAli Tavakoli
Ali Tavakoli
Reza KerachianReza Kerachian
Reza Kerachian
Mohammad Reza NikooMohammad Reza Nikoo
Mohammad Reza Nikoo
MSMaryam Soltani
Maryam Soltani
SESiamak Malakpour Estalaki
Siamak Malakpour Estalaki

19 July 2023 in Life
Verified
Journal Article
Open access
PDF file
APArdalan Pasdaran
Ardalan Pasdaran
BHBahareh Hassani
Bahareh Hassani
ATAli Tavakoli
Ali Tavakoli
Ekateina KozuharovaEkateina Kozuharova
Ekateina Kozuharova
AHAzadeh Hamedi
Azadeh Hamedi
The Latin word lupus, meaning wolf, was in the medical literature prior to the 1200s to describe skin lesions that devour flesh, and the resources available to physicians to help people were limited. The present text reviews the ethnobotanical and pharmacological aspects of medicinal plants and purified molecules from natural sources with efficacy against lupus conditions. Among these molecules are artemisinin and its derivatives, antroquinonol, baicalin, curcumin, emodin, mangiferin, salvianolic acid A, triptolide, the total glycosides of paeony (TGP), and other supplements such as fatty acids and vitamins. In addition, medicinal plants, herbal remedies, mushrooms, and fungi that have been investigated for their effects on different lupus conditions through clinical trials, in vivo, in vitro, or in silico studies are reviewed. A special emphasis was placed on clinical trials, active phytochemicals, and their mechanisms of action. This review can be helpful for researchers in designing new goal-oriented studies. It can also help practitioners gain insight into recent updates on supplements that might help patients suffering from lupus conditions.

11 October 2023 in Journal of Fluids Engineering
Verified
Journal Article
Closed access
PDF file
ATAli Tavakoli
Ali Tavakoli
Ehsan RoohiEhsan Roohi
Ehsan Roohi
MNMohammad Sanaee Namaghi
Mohammad Sanaee Namaghi
This study uses computational methods to investigate the fluid flow characteristics around a wavy NACA 63(4)-021 hydrofoil near the water surface. It introduces notable contributions to the literature on sinusoidal edge hydrofoils by examining the behavior of this specific hydrofoil configuration close to the water surface, a previously unexplored aspect. Furthermore, the study presents a comprehensive review and analysis of various machine learning (ML) techniques applied to computational fluid dynamics (CFD) and experimental data, offering a novel approach in this field. The three-dimensional Reynolds-averaged Navier–Stokes (RANS) equations are solved using an implicit finite volume approach to simulate the turbulent flow around the hydrofoil near the free surface. The realizable k–ε turbulence model accounts for turbulent flow effects at varying submergence depths. Four machine learning models in Python are developed to predict lift and drag coefficients. Evaluation of these models on training and test datasets reveals that xgboost achieves the highest accuracy, with an impressive R2 score of 0.9775 on the test dataset. Therefore, xgboost is recommended as the optimal model for future applications in this context. The study's findings are presented for the wavy hydrofoil at three submergence depths and three angles of attack (AOA). Key results include wave profiles, magnitudes, total pressure contours around the hydrofoil and free surface, and pressure, lift, and drag coefficients. The accuracy of the numerical simulations is validated by comparing the results with available experimental data, demonstrating good agreement between the two.

20 January 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HAHamide Ashraf
Hamide Ashraf
MHMojtaba Heydari
Mojtaba Heydari
MSMesbah Shams
Mesbah Shams
MZMohammad M. Zarshenas
Mohammad M. Zarshenas
ATAli Tavakoli
Ali Tavakoli
MSMehrab Sayadi
Mehrab Sayadi
Primary hypothyroidism is a common disease. Some patients have persistent symptoms despite normal serum thyroid-stimulating hormone (TSH) levels. Ginger is reported to be beneficial in relieving similar symptoms. Our aim was to evaluate the efficacy of ginger supplementation in relieving persistent symptoms in these patients. In this randomized, double-blind, placebo-controlled clinical trial, 60 hypothyroid patients aged 20–60 years with normal serum TSH concentrations were randomly allocated to two equal parallel study groups of ginger (500 mg twice a day) or placebo for 30 days. Hypothyroid symptoms were evaluated as the primary outcome using the Thyroid Symptom Rating Questionnaire (ThySRQ) before and after the intervention. Anthropometric measures and laboratory indices including TSH, triglyceride (TG), total cholesterol (TChol), and fasting blood sugar (FBS) were considered as secondary outcomes. A significant lower mean total ThySRQ score (8.63 ± 5.47 vs. 15.76 ± 6.09, ) was observed in the ginger group compared to the control group. Ginger led to significant improvements in the mean scores of the weight gain, cold intolerance, constipation, dry skin, appetite, memory loss, concentration disturbance, and feeling giddy or dizzy domains ( ). However, no significant improvements were observed in hair loss, nail fragility, hearing, hoarseness, speech, and depression or feeling down ( ). Ginger supplementation also led to a significant decrease in body weight, body mass index, waist circumference, serum TSH, FBS, TG, and TChol levels compared to the placebo. In summary according to preliminary results of this study, ginger supplementation can help relieve persistent hypothyroid symptoms. Also, it may have beneficial effects in terms of weight reduction and regulation of the FBS and lipid profile in hypothyroid patients.

2 August 2023 in European Journal of Integrative Medicine
Verified
Journal Article
Closed access
ZSZahra Salehi
Zahra Salehi
ATAli Tavakoli
Ali Tavakoli
SHSeyed Hassan Hamedi
Seyed Hassan Hamedi
SSSoodabeh Samimi
Soodabeh Samimi
FNForoogh Namjooyan
Foroogh Namjooyan
MSMehrab Sayadi
Mehrab Sayadi

18 February 2020 in The Open Dentistry Journal
Verified
Journal Article
Open access
PDF file
AKArezoo Khabazian
Arezoo Khabazian
ATAli Tavakoli
Ali Tavakoli
SSSamane Soltani
Samane Soltani
EKElaheh Karami
Elaheh Karami
NMNiloofar Mohaghegh
Niloofar Mohaghegh
Background: Crown lengthening surgery is one of the most common periodontal surgeries. The analgesic effects of benzydamine and ibuprofen tablets have been proven in various studies. The purpose of this study was to compare benzydamine hydrochloride mouthwash 0.15% with ibuprofen in decreasing the pain of patients with crown lengthening surgery who had referred to the Periodontology Department of Yazd Dentistry School in 2015. Materials & Methods: In this clinical trial study, 36 patients aged 30 to 60 years who referred to the Periodontal Department of the Dental Faculty of Yazd University of Medical Sciences needing a crown lengthening surgery were randomly allocated to two groups. The patients of the first group were asked to wash their mouth using benzydamine hydrochloride mouthwash 0.15% after the surgery according to the instructed protocol and the patients in the second group were asked to take an ibuprofen tablet (400 mg) every 6 hours. After 24 hours, the level of pain was measured by using the numerical criteria of the Visual Analog Scale (VAS) and the data were analyzed using SPSS software version 18. T test and Mann-Whitney test were used as appropriate. Results: 77.8% of the participants in the first group had mild pain and rest of the participants had moderate pain. 77.8% of the participants who used ibuprofen tablet reported mild pain, 16.7% had moderate pain and 5.6% had severe pain. The results did not illustrate more effect of ibuprofen on the reduction of pain after crown lengthening surgery compared with benzydamine hydrochloride 0.15% (P=0.48). Conclusion: In the present study, there were no changes in the VAS index between the two groups. Therefore, in order to decrease pain after periodontal surgery, benzydamine hydrochloride mouthwash can be widely used as it has fewer side effects, lower price, and similar effects with ibuprofen. Clinical Trial Registration Code: IRCT2016012312847N2.